Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-11 14:47:06 UTC |
---|
Updated at | 2022-09-11 14:47:07 UTC |
---|
NP-MRD ID | NP0315913 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | [(1s,3r,4s,5s,7r,9r,10s,11s,12r)-10-(furan-3-yl)-11-hydroxy-8-[(2-hydroxy-3-methylbutanoyl)oxy]-4-[(2r,3r)-2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-4,9-dimethyl-2-methylidene-6,13-dioxatetracyclo[7.4.0.0¹,¹².0³,⁷]tridecan-5-yl]acetic acid |
---|
Description | DYSOXYLUMIC ACID C, also known as dysoxylumate C, belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. It was first documented in 2022 (PMID: 36117663). Based on a literature review a significant number of articles have been published on DYSOXYLUMIC ACID C (PMID: 36095307) (PMID: 36099983) (PMID: 36059953) (PMID: 36045132). |
---|
Structure | CC(C)C(O)C(=O)OC1[C@@H]2O[C@@H](CC(O)=O)[C@](C)([C@H]3CC(=O)O[C@@]3(C)CO)[C@@H]2C(=C)[C@@]23O[C@@H]2[C@@H](O)[C@@H](C2=COC=C2)[C@]13C InChI=1S/C31H40O12/c1-13(2)22(36)27(38)41-26-24-20(14(3)31-25(43-31)23(37)21(30(26,31)6)15-7-8-39-11-15)29(5,17(40-24)10-18(33)34)16-9-19(35)42-28(16,4)12-32/h7-8,11,13,16-17,20-26,32,36-37H,3,9-10,12H2,1-2,4-6H3,(H,33,34)/t16-,17-,20+,21+,22?,23-,24+,25+,26?,28-,29-,30+,31+/m0/s1 |
---|
Synonyms | Value | Source |
---|
DYSOXYLUMate C | Generator |
|
---|
Chemical Formula | C31H40O12 |
---|
Average Mass | 604.6490 Da |
---|
Monoisotopic Mass | 604.25198 Da |
---|
IUPAC Name | 2-[(1S,3R,4S,5S,7R,9R,10R,11S,12R)-10-(furan-3-yl)-11-hydroxy-8-[(2-hydroxy-3-methylbutanoyl)oxy]-4-[(2R,3R)-2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-4,9-dimethyl-2-methylidene-6,13-dioxatetracyclo[7.4.0.0^{1,12}.0^{3,7}]tridecan-5-yl]acetic acid |
---|
Traditional Name | [(1S,3R,4S,5S,7R,9R,10R,11S,12R)-10-(furan-3-yl)-11-hydroxy-8-[(2-hydroxy-3-methylbutanoyl)oxy]-4-[(2R,3R)-2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-4,9-dimethyl-2-methylidene-6,13-dioxatetracyclo[7.4.0.0^{1,12}.0^{3,7}]tridecan-5-yl]acetic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)C(O)C(=O)OC1[C@@H]2O[C@@H](CC(O)=O)[C@](C)([C@H]3CC(=O)O[C@@]3(C)CO)[C@@H]2C(=C)[C@@]23O[C@@H]2[C@@H](O)[C@@H](C2=COC=C2)[C@]13C |
---|
InChI Identifier | InChI=1S/C31H40O12/c1-13(2)22(36)27(38)41-26-24-20(14(3)31-25(43-31)23(37)21(30(26,31)6)15-7-8-39-11-15)29(5,17(40-24)10-18(33)34)16-9-19(35)42-28(16,4)12-32/h7-8,11,13,16-17,20-26,32,36-37H,3,9-10,12H2,1-2,4-6H3,(H,33,34)/t16-,17-,20+,21+,22?,23-,24+,25+,26?,28-,29-,30+,31+/m0/s1 |
---|
InChI Key | SVDVIGFCUFHHRT-IFBANHPMSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Tricarboxylic acids and derivatives |
---|
Direct Parent | Tricarboxylic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tricarboxylic acid or derivatives
- Fatty acid ester
- Fatty acyl
- Oxane
- Gamma butyrolactone
- Heteroaromatic compound
- Tetrahydrofuran
- Furan
- Cyclic alcohol
- Secondary alcohol
- Lactone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Ether
- Oxirane
- Dialkyl ether
- Carboxylic acid
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Primary alcohol
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Hendra R, Salib MN, Molinski TF: Spiroisoxazoline Inhibitors of Acetylcholinesterase from Pseudoceratina verrucosa. Quantitative Chiroptical Analysis of Configurational Heterogeneity, and Total Synthesis of (+/-)-Methyl Purpuroceratate C. J Nat Prod. 2022 Sep 23;85(9):2207-2216. doi: 10.1021/acs.jnatprod.2c00595. Epub 2022 Sep 12. [PubMed:36095307 ]
- Yan M, Zhang Z, Liu Y: Difference analysis of different parts of chicory based on HPLC fingerprint and multi-component content determination. Chin Herb Med. 2022 Apr 2;14(2):317-323. doi: 10.1016/j.chmed.2022.01.006. eCollection 2022 Apr. [PubMed:36117663 ]
- Chen L, Zhou X, Deng Y, Yang Y, Chen X, Chen Q, Liu Y, Fu X, Kwan HY, You Y, Jin W, Zhao X: Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway. J Ethnopharmacol. 2023 Jan 10;300:115705. doi: 10.1016/j.jep.2022.115705. Epub 2022 Sep 12. [PubMed:36099983 ]
- Yang J, Li C, Liu Y, Han Y, Zhao H, Luo S, Zhao C, Jiang N, Yang M, Sun L: Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease. Front Pharmacol. 2022 Aug 19;13:832299. doi: 10.3389/fphar.2022.832299. eCollection 2022. [PubMed:36059953 ]
- Zeng H, Pan T, Zhan M, Hailiwu R, Liu B, Yang H, Li P: Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. Signal Transduct Target Ther. 2022 Sep 1;7(1):303. doi: 10.1038/s41392-022-01097-6. [PubMed:36045132 ]
- LOTUS database [Link]
|
---|